16051-25-5

Basic information

• Product Name: scyllo-Inositol,1-amino-1-deoxy-
• Synonyms: Inositol,1-amino-1-deoxy-, scyllo- (8CI); 1-Amino-1-deoxy-scyllo-inositol;Aminodeoxy-scyllo-inositol; Bluensamine; Scylloinosamine; scyllo-Inosamine;scyllo-Inosamine-2
• CAS NO: 16051-25-5
• Molecular Formula: C6H13 N O5
• Molecular Weight: 179.173
• Mol File: 16051-25-5.mol

Chemical Properties

• CAS DataBase Reference: scyllo-Inositol,1-amino-1-deoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: scyllo-Inositol,1-amino-1-deoxy-(16051-25-5)
• EPA Substance Registry System: scyllo-Inositol,1-amino-1-deoxy-(16051-25-5)

Safety Data

• Hazardous Substances Data: 16051-25-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Scyllo-Inositol,1-amino-1-deoxyis used as a therapeutic agent for the treatment of neurodegenerative diseases such as Alzheimer's disease. Its neuroprotective and neurotrophic properties make it a promising candidate for the development of new drugs to address these disorders.
Used in Drug Development:
Scyllo-Inositol,1-amino-1-deoxyis used as a key component in the research and development of new drugs targeting neurological disorders. Its potential therapeutic effects and ongoing research make it a valuable asset in the advancement of treatments for neurodegenerative diseases.

Upstream product

• 67-56-1 methanol 
• 7045-48-9 myo-inosose-⁽²⁾-phenylhydrazone 
• 7045-47-8 (+/-)-epi-inosose-⁽²⁾-phenylhydrazone 
• 6556-12-3 D-glucuronic acid 
• 4969-30-6 (2R,3R,4S,6R)-6-Nitro-cyclohexane-1,2,3,4,5-pentaol 
• 22263-78-1 D-myo-Inosose-⁽¹⁾-phenylhydrazon; (-)-vibo-Inosose-phenylhydrazon 
• 7664-41-7 ammonia 
• 18391-54-3 1D-O³,O⁴;O⁵,O⁶-diisopropyliden-1,2-anhydro-allo-inositol 
• 4969-30-6 muco-nitrocyclitol 
• 852045-20-6 (1s,2R,3S,4r,5R,6S)-2,3,4,5,6-pentakis(benzyloxy)cyclohexanamine 
• 4969-30-6 scyllo-nitrocyclitol 
• 868550-22-5 (1S,2S,3R,4R,5S,6R)-1-azido-2,3,4,5,6-pentakis-benzyloxycyclohexane 
• 133218-74-3 4,5,6-tri-O-benzyl-1,2-anhydro-myo-inositol 

Downstream Products

• 7011-06-5 penta-O-acetyl-1-acetylamino-1-deoxy-scyllo-inositol 
• 64938-54-1 1D-penta-O-acetyl-1-acetylamino-1-deoxy-myo-inositol 
• 20097-49-8 penta-O-acetyl-3-acetylamino-3-deoxy-muco-inositol 
• 3613-86-3 N-Acetyl-muco-inosamin-⁽³⁾ 
• 3613-86-3 1-acetylamino-1-deoxy-scyllo-inositol 
• 3613-86-3 N-acetyl-myo-inosamine 
• 2772-86-3 DL-penta-O-acetyl-2-acetylamino-2-deoxy-epi-inositol 
• 2772-86-3 DL-penta-O-acetyl-4-acetylamino-4-deoxy-myo-inositol 
• 77123-07-0 N-acetylaminocyclitol pentaacetate 
• 1281973-56-5 (1R,2S,3r,4R,5S,6s)-6-[(1-(3,5-bis(benzyloxy)benzyl)-1H-1,2,3-triazol-4-yl)methylamino]cyclohexane-1,2,3,4,5-pentaol 
• 3613-86-3 2-acetylamino-2-deoxy-myo-inositol 

Relevant articles and documents

Small-scale one-pot reductive alkylation of unprotected aminocyclitols with supported reagents

A protocol for the reductive alkylation of unprotected aminocyclitols with supported reagents and scavengers is described. The method is operatively simple and provides the corresponding secondary amines in high yields and purities. Georg Thieme Verlag Stuttgart.

New aminocyclitols as modulators of glucosylceramide metabolism

A series of 13 aminocyclitol derivatives belonging to two different families is described. Their configuration is governed by the regio- and stereocontrolled epoxide opening of a suitably protected conduritol-B epoxide. Studies on several glycosyl processing enzymes indicate that some of them are good inhibitors of glucosylceramide hydrolase. A rationale to account for preliminary structure-activity relationships is provided. The Royal Society of Chemistry 2005.